Across New Jersey, where winter illnesses routinely fill emergency departments and send school and work absences soaring, the annual flu season remains an expensive, predictable disruptor in the lives of hundreds of thousands of New Jerseyans. Yet more than a third of New Jersey residents say no to the vaccine, despite its proven track record of preventing hospitalization and death.
As parents and pediatricians know all too well, it’s important to tell the truth when something is going to hurt. If you lie to a child about the shot they’re about to receive and promise it will “just pinch a little,” you lose their trust the moment their arm burns and aches for the rest of the day. Adults are no different. So why do we sometimes treat them like they can’t handle the truth?
Every year, millions of Americans get the flu. Hundreds of thousands are hospitalized, and tens of thousands die. Even during so-called “mild” flu seasons, the toll can be high: missed work or school, surprise medical bills, and derailed family plans all sting, even when illness isn’t severe. And for older people, pregnant women, and young children, flu can be especially serious.
It’s no wonder only about 60% of New Jerseyans got the flu vaccine in 2024. Misperceptions persist, like the stubborn myth that the inactivated virus in the flu shot can give you the flu (it can’t!), along with valid frustrations that the vaccine isn’t 100% effective (but even if you still get the flu after your shot, it can take the illness from “wild to mild” and prevent serious illness and hospitalization). But there’s another reason people skip the annual flu shot: it can make you feel crummy for a day or two. Public health campaigns sometimes gloss over this reality, and it hurts people’s trust.
Beyond side effects, public hesitation is fueled by the shot’s hit-or-miss reputation, which is a direct consequence of the flu shot’s outdated manufacturing pipeline. For decades, the vaccine has relied on a manufacturing process that goes back to the 1940s. That process, which relies on growing flu virus in chicken eggs, takes six to nine months. As a result, health authorities have to decide which flu strains to include in the annual shot every February — roughly nine months before the next flu season begins — based on early forecasts of what the following year might look like.
This fall, we have a new tool in our fight against seasonal flu: the first mRNA influenza vaccine, mFLUVISA, approved for adults 50 and older. Built on the same technology that has helped to deliver billions of doses of Covid vaccine, the mRNA flu vaccine can be manufactured in just six weeks. This shorter lead time means that regulators could eventually allow scientists to wait until late summer to finalize which viral strains to cover in the annual shot, allowing for much better matches between the vaccine and the seasonal virus and resulting in better protection. And even without a better match to the annual strains, the mRNA flu vaccine appears to be more effective than the conventional vaccine. In clinical trials among older adults, it was roughly 27% more effective at preventing flu, even though it covered the same strains that were picked months earlier for the conventional shot.
There’s a catch, though, and we need to be completely honest about it. Similar to the Covid vaccine, the mRNA flu vaccine causes minor side effects like fever, a sore arm, chills, or muscle aches about twice as often as the traditional flu vaccine. Rather than downplaying those possibilities, pharmacists and doctors must be candid. A mild, brief fever isn’t a failure of the shot. It’s evidence that your immune system is building your defenses against the flu, though recipients who breeze through without a single side effect are just as protected.
Tell people what to expect and help them plan. Schedule your vaccine for a Friday afternoon. Stock the fridge, prepare for a weekend of binge-watching your favorite shows, or carve out some couch time for Sunday football. Most people are more than willing to trade 24 hours of rest for months of protection against an illness that could land them or an elderly relative in the hospital. Notably, women are more likely than men to experience side effects from the flu vaccine, so planning ahead can be even more useful in that case.
That honesty will matter even more if we face an emerging pandemic strain like avian influenza, commonly known as bird flu. Because outbreaks have already devastated commercial poultry flocks, relying on egg-based manufacturing leaves our vaccine supply chain dangerously vulnerable. mRNA flu vaccines are going to be one of our best defenses in a bird flu pandemic because they bypass chickens altogether and allow us to manufacture and deliver vaccines to the public quickly. We need people to be ready to take these shots, even if it makes them feel a bit under the weather for a day or two.
As the classic PBS Kids show Sid the Science Kid once described the annual flu shot, “It might hurt a little bit, but it’s gonna help a whole lot!” If we treat adults with that same simple honesty, we can build the trust needed to keep our communities healthy and protected.

